TipRanks
Go Ultimate55% OFF

Daniel Junius Insider Profile

4 Followers

Daniel Junius, Director at Idexx Laboratories, holds 3.56K shares in Idexx Laboratories (Ticker: IDXX), holds 98.46K shares in Crescent Biopharma (Ticker: CBIO), holds 184.99K shares in ImmunoGen (Ticker: IMGN).

Daniel Junius's Trading History

IDXX
Idexx Laboratories
May 11, 2026DirectorUninformative Buy147.06K$1.96M
CBIO
Crescent Biopharma
Apr 02, 2024DirectorUninformative Buy15.63K$1.33M
IMGN
ImmunoGen
Feb 23, 2018―Informative Sell140.56K$5.78M
VTAE
Vitae Pharma
――――

You May Also Like

Daniel Junius insider profile FAQ

What is the percentage of profitable transactions made by Daniel Junius?
The percentage of profitable transactions made by Daniel Junius is 42%.
What is the average return per transaction made by Daniel Junius?
The average return per transaction made by Daniel Junius is -1.90%.
What stocks does Daniel Junius hold?
Daniel Junius holds: IDXX, IMGN, CBIO, VTAE stocks.
What was Daniel Junius’s latest transaction?
Daniel Junius’s latest transaction was an Uninformative Buy of $147.06K.
What was Daniel Junius's most profitable transaction?
Daniel Junius’s most profitable transaction was an Informative Buy of CBIO stock on December 21, 2016. The return on the trade was 168.10%.
What is Daniel Junius's role in Idexx Laboratories?
Daniel Junius's role in Idexx Laboratories is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.